WuXi Biologics (Cayman), Inc. (WXIBF)
6.15
-0.06
(-0.97%)
USD |
OTCM |
Nov 13, 16:00
WuXi Biologics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Austar Lifesciences Ltd. | -- |
| Agilent Technologies, Inc. | 6.662 |
| Bio-Rad Laboratories, Inc. | 1.296 |
| Bruker Corp. | 4.115 |
| Azenta, Inc. | 1.364 |
Price to Book Value Related Metrics
| PE Ratio | 36.07 |
| PS Ratio | 7.597 |
| PEG Ratio | 0.3446 |
| Price to Free Cash Flow | 40.81 |
| Price | 6.15 |
| Earnings Yield | 2.77% |
| Market Cap | 25.25B |
| PEGY Ratio | 0.3446 |
| Operating PE Ratio | 23.47 |
| Normalized PE Ratio | 38.41 |